Myeloid cells chiefly regulate such mechanisms of sIL-6R-mediated immune suppression, along with IL-6-dependent inflammatory processes [103] in the TME have been linked to tumor progression and poor prognosis in several solid cancers, including gastric, breast [106], colorectal [110], ovarian [107], and lung [109]. Here, IL6R is linked to neoplasm.